Another Kemco RPG is getting the Limited Run Games treatment. PlayStation 4 owners will soon be able to add Seek Hearts to their physical collection.
Japanese players have been escorting Escude in Frane: Dragons’ Odyssey for nearly two decades. Now, Limited Run Games is releasing the overhauled 2019 version in physical form.
Limited Run Games has a couple of physical releases of potential interest to RPGamers. Away: Journey to the Unexpected is available to order now, with Illusion of L’Phalcia to come in two limited batches on Friday.
Kemco has announced a new set of releases. Frane: Dragons’ Odyssey comes to PS4 and Vita, while Legend of the Tetrarchs and Marenian Tavern Story head to Xbox One and Windows 10.
Kemco has put out some new RPG releases. The latest releases feature a couple of titles from developer EXE-Create.
A new RPG will be available to order from Limited Run Games tomorrow. The latest title getting the physical treatment is Kemco and EXE-Create’s Fernz Gate.
The latest news from Kemco concerns a couple of Steam releases. Chronus Arc arrives on the store having released on the Windows Store last month, while Asdivine Hearts II receives its first non-mobile platform.
Kemco and EXE-Create’s Revenant Dogma is out now on PC and Switch. The new platforms make it a complete set for the current generation of systems.
Kemco and EXE-Create’s Fernz Gate is now available on PC and consoles. The company will also be releasing another title soon enough, with Revenant Dogma getting a firm date for PC and Xbox One.
Giant dragons appear to like being given human sacrifices to relieve their appetites. Admittedly, this game and the movie Dragon Slayer aren’t a conclusive survey group, but there’s a definite pattern. A merchant, a baker and a revenant maker.
In Asdivine Hearts players are introduced to talking cats, some sweet romance, and every trope that ever troped. Way to go Kemco.
The all-too-brief length of game titles just not cutting it? Then Exe-Create might have the game for you. For more details, please consult our review.